Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)

Kihwan Hwang, Tae Min Kim, Chul Kee Park, Jong Hee Chang, Tae Young Jung, Jin Hee Kim, Do Hyun Nam, Se Hyuk Kim, Heon Yoo, Yong Kil Hong, Eun Young Kim, Dong Eun Lee, Jungnam Joo, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok Gu Kang, Jeong Hoon Kim, Chae Yong Kim

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)'. Together they form a unique fingerprint.

Medicine & Life Sciences